Similarly, high expression of FN1 may be a positive tumor biomarker contributing to invasive breast cancer, pancreatic ductal adenocarcinoma (PDAC), and renal cell carcinoma (RCC) [[43], [44], [45]]. Here, FN1 is linked to invasive breast carcinoma.